Overview
- The administration announced a deal for EMD Serono to offer discounted IVF medications Gonal-F, Ovidrel and Cetrotide on the planned TrumpRx site starting in early 2026.
- Officials said prices could be 42% to 79% below current levels depending on income, while the company said eligible patients using its full protocol could see up to an 84% discount off list prices.
- Forthcoming guidance from HHS, Treasury and Labor will allow employers to offer stand‑alone or supplemental fertility benefits outside major medical plans, but participation will be voluntary and not subsidized.
- The package includes expedited FDA review for Pergoveris, a fertility drug already sold in Europe, and trade incentives tied to U.S. manufacturing; CVS Specialty and Express Scripts’ Freedom Fertility agreed to lower handling costs.
- Because medications are only one component of IVF—total cycles often run $15,000 to $30,000—experts say the overall out‑of‑pocket reduction remains uncertain, even as drug costs per cycle are projected to fall for many patients.